The clinical data analytics market is experiencing growth due to a rise in chronic diseases. Cloud computing plays a pivotal...
Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by...
Collaborations empower the healthcare industry to create a vast array of medical imaging copilot applications that will help enhance radiologists'...
PASADENA, Calif., July 24, 2024 /PRNewswire/ -- Deep 6 AI, the leader in AI-powered patient recruitment and real-world data (RWD), announced...
Company's virtual therapeutic programs and proprietary risk stratification algorithm support proactive detection of and intervention for cognitive decline BOSTON, July...
EDEN PRAIRIE, Minn., July 24, 2024 /PRNewswire/ -- inFormed Consent, a pioneer in digital informed consent and patient education technology,...
Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform CAMBRIDGE, Mass., July 24, 2024 /PRNewswire/ -- Insilico Medicine...
NEW YORK, July 24, 2024 /PRNewswire/ -- Datavant, the leading health data platform company, announced today its upcoming participation in...
New capability provides sponsors and CROs holistic view of sites' patient recruitment progress COLUMBIA, Md., July 24, 2024 /PRNewswire/ -- Advarra, the...
Trial is first of its kind to measure EF severity direct-from-ECG NEW YORK, July 24, 2024 /PRNewswire/ -- Peerbridge Health...
SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the...
Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component...
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s...
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular...
MALVERN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),...
Presentations will include an encore of the positive interim Phase 1/2 results presented in April at the 76th Annual American...
MELBOURNE, Australia and SAN FRANCISCO, July 24, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
BOSTON and SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in at-home sleep monitoring and computational...
Phase 2 dosing plan, agreed with FDA, paves the way to initiate patient enrollmentFOSTER CITY, Calif., July 24, 2024 (GLOBE...